Shield Therapeutics : Australia’s Therapeutic Goods Administration (TGA) approves Feraccru® to treat Iron Deficiency with or without anaemia in adults

THE MATERIALS ARE RESTRICTED AND ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR PERSONS IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THE MATERIALS WOULD BREACH ANY APPLICABLE LAW OR REGULATION OR WOULD REQUIRE ANY REGISTRATION OR LICENSING WITHIN SUCH JURISDICTION

Please read this notice carefully. It applies to all persons who view this site. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site

Overseas Persons

Viewing the information contained on this site may be restricted in certain jurisdictions. The information published or made available via this site is not intended to be published or made available in any jurisdiction where to do so would result in the breach of any applicable law or regulation in that jurisdiction or would require any registration or licensing in that jurisdiction.

The information contained on this site are directed only to persons who are: (1) in Member States of the European Economic Area, qualified investors as defined in article 2(e) of the Prospectus Regulation (EU) 2017/1129; (2) in the United Kingdom, qualified investors as defined in article 2(e) of Prospectus Regulation (EU) 2017/1129 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, who (A) fall within article 19(5) ('investment professionals') of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the 'Order'), or (B) fall within article 49(2)(a) to (d) ('high net worth companies, unincorporated associations, etc.') of the Order; or (3) are persons to whom it may otherwise be lawfully communicated; (all such persons together being referred to as 'relevant persons'). Any investment or investment activity to which the information contained on this site relate, is available only to relevant persons.

You should satisfy yourself before accessing the site that you are permitted to view the information and materials on this site under the laws and regulations of your jurisdiction.

The ordinary shares in Shield Therapeutics plc have not been, and will not be, registered under the U.S. Securities Act of 1933 as amended (the 'Securities Act') or qualified for sale under the laws of any state of the United States or under the applicable laws of any of Australia, Canada, Japan or the Republic of South Africa and, subject to certain exceptions, may not be offered or sold in the United States or to, or for the account or benefit of, US persons (as such term is defined in Regulation S under the Securities Act) or to any national, resident or citizen of Australia, Canada, Japan or the Republic of South Africa.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this web page.

The materials on this site (including the Circular nor any copy of it) must not be released or otherwise forwarded, distributed or sent, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan, the Republic of South Africa or any jurisdiction where the distribution of the materials would breach any applicable law or regulation or would require any registration or licensing within such jurisdiction.

Basis of Access

Access to electronic versions of the materials is being made available on this website by Shield Therapeutics plc for information purposes only. Any person seeking access to this website represents and warrants to Shield Therapeutics plc that they are doing so for information purposes only. Making documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in Shield Therapeutics plc. Further, it does not constitute a recommendation by Shield Therapeutics plc or any other party to sell or buy securities in Shield Therapeutics plc.

No representation or warranty, express or implied, is given by or on behalf of Peel Hunt LLP and finnCap Ltd (together the 'Banks') or any of such persons' affiliates or their respective directors, officers or employees or any other person as to the accuracy or completeness of the information or opinions contained on this website and no liability whatsoever is accepted by the Banks or any of such persons' affiliates or their respective directors, officers or employees or any other person for any loss howsoever arising, directly or indirectly, from any use of such information or opinions or otherwise arising in connection therewith.

Please note that the information appearing in the materials is accurate only as of the date of the relevant document, regardless of the time of delivery of the document or of any offer or sale of the securities. Each of Shield Therapeutics plc and the Banks expressly disclaim any duty to update the materials except as required by applicable law.

The information on this site is made available in accordance with Rule 26 of the AIM Rules for Companies.

By clicking on the 'I Agree' button, I confirm that:

1. I have read, understood and agree to be bound by the terms of the notice set out above;
2. I warrant and represent that I am not a resident of, or otherwise located in, the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where accessing the information on this site would constitute a violation of the relevant laws or regulations of that jurisdiction or would require any registration or licensing within such jurisdiction;
3. I agree that I will not transmit or otherwise send (directly or indirectly) any information on this site to any person in the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where accessing the information on this site would constitute a violation of the relevant laws or regulations of that jurisdiction or would require any registration or licensing within such jurisdiction; and
4. I confirm that I am not a person to whom the communication of the information contained on the site is restricted and are not acting for the benefit of any such person.

I Do Not Agree